Plasma lipid concentrations after 1.5 years of exposure to nevirapine or efavirenz together with stavudine and lamivudine

F. van Leth, D.B. Hall, J.M.A. Lange, P. Reiss

Research output: Contribution to JournalArticleAcademicpeer-review

Abstract

Objectives: To assess long-term changes in lipids and lipoproteins concentrations associated with exposure to non-nucleoside reverse transcriptase inhibitors. Methods: Long-term analysis of plasma lipid concentrations was performed in patients starting first-line antiretroviral therapy with stavudine (d4T) and lamivudine, and either nevirapine or efavirenz. Results: Concentrations of total cholesterol, low-density lipoprotein cholesterol and triglycerides continued to increase, while high-density lipoprotein cholesterol showed a slight decrease compared with earlier reported increases after 48 weeks. Conclusions: Changes in body fat distribution expected to occur with continued exposure to d4T could offer a potential explanation for these findings. © 2006 British HIV Association.
Original languageEnglish
Pages (from-to)347-350
JournalHIV Medicine
Volume7
Issue number6
DOIs
Publication statusPublished - Sep 2006
Externally publishedYes

Fingerprint

Dive into the research topics of 'Plasma lipid concentrations after 1.5 years of exposure to nevirapine or efavirenz together with stavudine and lamivudine'. Together they form a unique fingerprint.

Cite this